Volume 11 (2013): Issue 3 (Mar 2013)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xii
Oncology Research Program
Pages: xxi–xxii
JNCCN CE Offerings
Pages: xxiii
Keeping Cancer Patients Out of the Hospital at the End of Life
By: Harold J. Burstein
Pages: 229–230
In Chemotherapy for Lung Cancer, Sometimes Less is More
By: Eric Roeland, Charles Loprinzi, Timothy J. Moynihan, Thomas J. Smith, and Jennifer Temel
Pages: 232–235
Part 1: Abstracts From the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™
Pages: 240–245
Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations
By: Gayathri Nagaraj and Cynthia X. Ma
Pages: 246–251
Non-Hodgkin’s Lymphomas, Version 1.2013
By: Andrew D. Zelenetz, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis E. Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Mary A. Dwyer, and Maoko Naganuma
Pages: 257–273
Cutaneous T-Cell Lymphoma in Sub-Saharan Africa
By: Matthew Ulrickson, Fred Okuku, Victoria Walusansa, Oliver Press, Sam Kalungi, David Wu, Fred Kambugu, Corey Casper, and Jackson Orem
Pages: 275–280
Point: Impact of Prostate-Specific Antigen Velocity on Management Decisions and Recommendations
By: Stacy Loeb and H. Ballentine Carter
Pages: 281–285
Counterpoint: Prostate-Specific Antigen Velocity Is Not of Value for Early Detection of Cancer
By: Andrew J. Vickers
Pages: 286–290
Optimizing Neoadjuvant Therapy for Rectal Cancer With Oxaliplatin
By: Ludmila Katherine Martin and Tanios Bekaii-Saab
Pages: 298–307
Maintenance Therapy With Tyrosine Kinase Inhibitors After Transplant in Patients With Chronic Myeloid Leukemia
By: Merav Bar and Jerald Radich
Pages: 308–315
Cervical Cancer
By: Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, David Cohn, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Robert L. Giuntoli II, Ernest Han, Warner K. Huh, John R. Lurain III, Lainie Martin, Mark A. Morgan, David Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small Jr, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Nicole R. McMillian, and Miranda Hughes
Pages: 320–343
What Is the Appropriate Approach to Treating Women With Incurable Cervical Cancer?
By: Lois Ramondetta
Pages: 348–355
A Perspective on Dose Banding
By: Jake B. Guinto and Audrea H. Szabatura
Pages: 357–359
  • Collapse
  • Expand